AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SAB Biotherapeutics, Inc. Director's Dealing 2021

Jan 11, 2021

34961_dirs_2021-01-11_ede15c67-13ca-4bac-ab9f-6865aa08cd88.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Big Cypress Acquisition Corp. (BCYP)
CIK: 0001833214
Period of Report: 2021-01-11

Reporting Person: Big Cypress Holdings LLC (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2630625	Direct

Footnotes

F1: Includes up to 343,125 shares subject to forfeiture by Big Cypress Holdings LLC (the "Sponsor") depending on the extent to which the underwriters' option to purchase additional units is exercised.

F2: The securities are held directly by the Sponsor and indirectly by Samuel J. Reich and Ilan Katz as managers of the Sponsor.